Antibody-Drug Conjugation Service Market

The global Antibody-Drug Conjugation Service market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.

Antibody Services Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Antibody-Drug Conjugation Service include BOC Sciences, Abzena, Creative Biolabs, WuXi XDC, Merck KGaA, Piramal, Charles River, Syngene and Novasep, etc. in 2023, the global top five players have a share approximately % in terms of revenue.

Antibody-Drug Conjugation Service Market aims to provide a comprehensive presentation of the global market for Antibody-Drug Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody-Drug Conjugation Service. Antibody-Drug Conjugation Service Market contains market size and forecasts of Antibody-Drug Conjugation Service in global, including the following market information:

Global Antibody-Drug Conjugation Service Market Revenue, 2019-2024, 2025-2030, ($ millions)

Global top five companies in 2023 (%)

We surveyed the Antibody-Drug Conjugation Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody-Drug Conjugation Service Market, by Type, 2019-2024, 2025-2030 ($ millions)

Global Antibody-Drug Conjugation Service Market Segment Percentages, by Type, 2023 (%)

Antibody Services

Payload Services

Linker Services

Other

Global Antibody-Drug Conjugation Service Market, by Application, 2019-2024, 2025-2030 ($ millions)

Global Antibody-Drug Conjugation Service Market Segment Percentages, by Application, 2023 (%)

Breast Cancer

Lymphoma

Other

Global Antibody-Drug Conjugation Service Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)

Global Antibody-Drug Conjugation Service Market Segment Percentages, By Region and Country, 2023 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibody-Drug Conjugation Service revenues in global market, 2019-2024 (estimated), ($ millions)

Key companies Antibody-Drug Conjugation Service revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

BOC Sciences

Abzena

Creative Biolabs

WuXi XDC

Merck KGaA

Piramal

Charles River

Syngene

Novasep

Seagen

Levena Biopharma

Outline of Major Chapters:

Chapter 1: Introduces the definition of Antibody-Drug Conjugation Service, market overview.

Chapter 2: Global Antibody-Drug Conjugation Service market size in revenue.

Chapter 3: Detailed analysis of Antibody-Drug Conjugation Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antibody-Drug Conjugation Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.